Duke Pathology Leads, Teaches, and Inspires at the NCSH Spring Conference
Duke Pathology had a strong presence at the North Carolina Society of Histotechnology (NCSH) Spring Meeting held March 12-14 in Durham, North Carolina.
Duke Pathology Well Represented at the United States and Canadian Academy of Pathology (USCAP) Annual Meeting
Duke Pathology had a strong presence at the United States and Canadian Academy of Pathology (USCAP) Annual Meeting in San Antonio, Texas, from March 21-26, 2026.
From Biopsy to Breakthrough: Duke Students Dive into the Diagnostic Process
On March 11, 2026, the Duke Pathology Interest Group hosted “How is a Diagnosis REALLY made?
New Ranking Highlights NIH’s Impact on Breakthrough Science at Duke Pathology
Duke Pathology received more than $13 million in research funding from the National Institutes of Health (NIH) in 2025, with Duke University School of Medicine r
Dr. John Toffaletti Co-Authors Landmark Study Showing How Shunt Valve Equations are Calculated
Duke Pathology Professor John Toffaletti, PhD, co‑authored a study titled
From Brain Tissue to Blood Tests: Dr. Shih-Hsiu "Jerry" Wang's Research Featured as Translational Science Case Study
Given recent successful developments in treatment for early-stage Alzheimer’s disease, there is a need for tests that allow early diagnosis and prognosis assessment. Duke Pathology's Shih-Hsiu “Jerry” Wang, MD, PhD, and NCCU's Bin Xu, PhD, partnered to conduct research to develop minimally invasive tests for earlier disease diagnosis and monitoring severity